These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23627014)

  • 1. [Prior infected influenza virus could protect mice from challenge of lethal influenza virus].
    Liu LQ; Li Z; Zhu Y; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):405-8. PubMed ID: 23627014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
    Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A live bivalent influenza vaccine based on a H9N2 virus strain.
    Wu R; Guan Y; Yang Z; Chen J; Wang H; Chen Q; Sui Z; Fang F; Chen Z
    Vaccine; 2010 Jan; 28(3):673-80. PubMed ID: 19892041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
    Wodal W; Falkner FG; Kerschbaum A; Gaiswinkler C; Fritz R; Kiermayr S; Portsmouth D; Savidis-Dacho H; Coulibaly S; Piskernik C; Hohenadl C; Howard MK; Kistner O; Barrett PN; Kreil TR
    Vaccine; 2012 Jun; 30(31):4625-31. PubMed ID: 22580355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A DNA vaccine expressing PB1 protein of influenza A virus protects mice against virus infection.
    Košík I; Krejnusová I; Práznovská M; Poláková K; Russ G
    Arch Virol; 2012 May; 157(5):811-7. PubMed ID: 22294447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.
    Ernst WA; Kim HJ; Tumpey TM; Jansen AD; Tai W; Cramer DV; Adler-Moore JP; Fujii G
    Vaccine; 2006 Jun; 24(24):5158-68. PubMed ID: 16713037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
    Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z
    Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.
    Sandbulte MR; Jimenez GS; Boon AC; Smith LR; Treanor JJ; Webby RJ
    PLoS Med; 2007 Feb; 4(2):e59. PubMed ID: 17298168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice.
    Zheng B; Chan KH; Zhang AJ; Zhou J; Chan CC; Poon VK; Zhang K; Leung VH; Jin DY; Woo PC; Chan JF; To KK; Chen H; Yuen KY
    Exp Biol Med (Maywood); 2010 Aug; 235(8):981-8. PubMed ID: 20660098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune Protection against H9N2 Provided by H1N1 Pre-infection in Pigs].
    Wang J; Wu M; Hong W; Zheng Z; Chen R
    Bing Du Xue Bao; 2015 Jul; 31(4):357-62. PubMed ID: 26524907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of avian H9N2 influenza viruses in a murine model.
    Wu R; Sui Z; Liu Z; Liang W; Yang K; Xiong Z; Xu D
    Vet Microbiol; 2010 May; 142(3-4):211-6. PubMed ID: 19900767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to influenza A H9N2 viruses induced by infection and vaccination.
    Lu X; Renshaw M; Tumpey TM; Kelly GD; Hu-Primmer J; Katz JM
    J Virol; 2001 May; 75(10):4896-901. PubMed ID: 11312361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.
    Song Y; Wang X; Zhang H; Tang X; Li M; Yao J; Jin X; Ertl HC; Zhou D
    J Virol; 2015 Aug; 89(15):7841-51. PubMed ID: 25995265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.
    Shi J; Wen Z; Guo J; Zhang Y; Deng G; Shu Y; Wang D; Jiang Y; Kawaoka Y; Bu Z; Chen H
    Antiviral Res; 2012 Mar; 93(3):346-53. PubMed ID: 22281419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human intestinal epithelial cells are susceptible to influenza virus subtype H9N2.
    Qu B; Li X; Gao W; Sun W; Jin Y; Cardona CJ; Xing Z
    Virus Res; 2012 Jan; 163(1):151-9. PubMed ID: 21986059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM
    Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.